scholarly journals Genetic counseling in industry settings: Opportunities in the era of precision health

Author(s):  
Kirsty McWalter ◽  
Megan T. Cho ◽  
Tara Hart ◽  
Rachel Nusbaum ◽  
Courtney Sebold ◽  
...  
2015 ◽  
Author(s):  
Melissa A. Geller ◽  
Hee Y. Lee ◽  
Kristin Niendorf ◽  
Rachel I. Vogel ◽  
Heewon Lee

Author(s):  
Deborah Cragun ◽  
Lucia Camperlengo ◽  
Emily Robinson ◽  
Pauleena Pal ◽  
Jongphil Kim ◽  
...  

2020 ◽  
Author(s):  
Nigel Armstrong ◽  
Ruben GW Quek ◽  
Steve Ryder ◽  
Janine Ross ◽  
Titas Buksnys ◽  
...  

Background: Ongoing clinical trials are investigating poly(ADP-ribose) polymerase (PARP) inhibitors to target the DNA damage repair (DDR) pathway in prostate cancer. DDR mutation screening will guide treatment strategy and assess eligibility for clinical trials. Materials & methods: This systematic review estimated the rate of DDR mutation testing or genetic counseling among men with or at risk of prostate cancer. Results: From 6856 records, one study fulfilled the inclusion criteria and described men undiagnosed with prostate cancer with a family history of BRCA1/2 mutation who received DDR mutation testing. Conclusion: With only one study included in this first systematic review of DDR mutation testing or genetic counseling in men with or at risk of prostate cancer, more research is warranted.


Allergy ◽  
2019 ◽  
Vol 75 (4) ◽  
pp. 936-940 ◽  
Author(s):  
Oscar Palomares ◽  
Eva Untersmayr ◽  
Jan Gutermuth ◽  
Ioana Agache ◽  
Sofia Ajeganova ◽  
...  

Author(s):  
M. Sazzad Hussain ◽  
David Silvera-Tawil ◽  
Geremy Farr-Wharton

Abstract Objective Established and emerging technologies—such as wearable sensors, smartphones, mobile apps, and artificial intelligence—are shaping positive healthcare models and patient outcomes. These technologies have the potential to become precision health (PH) innovations. However, not all innovations meet regulatory standards or have the required scientific evidence to be used for health applications. In response, an assessment framework was developed to facilitate and standardize the assessment of innovations deemed suitable for PH. Methods A scoping literature review undertaken through PubMed and Google Scholar identified approximately 100 relevant articles. These were then shortlisted (n = 12) to those that included specific metrics, criteria, or frameworks for assessing technologies that could be applied to the PH context. Results The proposed framework identified nine core criteria with subcriteria and grouped them into four categories for assessment: technical, clinical, human factors, and implementation. Guiding statements with response options and recommendations were used as metrics against each criterion. Conclusion The proposed framework supports health services, health technology innovators, and researchers in leveraging current and emerging technologies for PH innovations. It covers a comprehensive set of criteria as part of the assessment process of these technologies.


Sign in / Sign up

Export Citation Format

Share Document